These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 27636124

  • 1. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
    Luersen GF, Wei W, Tamm EP, Bhosale PR, Szklaruk J.
    J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
    [Abstract] [Full Text] [Related]

  • 2. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R, Vietti-Violi N, Duran R, Knebel JF, Ledoux JB, Dromain C.
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [Abstract] [Full Text] [Related]

  • 3. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D.
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [Abstract] [Full Text] [Related]

  • 4. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [Abstract] [Full Text] [Related]

  • 5. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G, Fina P, Bruno O, Vullierme MP, Tubach F, Paradis V, Sauvanet A, Ruszniewski P, Vilgrain V.
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [Abstract] [Full Text] [Related]

  • 6. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E, Long W, Luo L, Hu M, Huang L, Chen X.
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [Abstract] [Full Text] [Related]

  • 7. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA.
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [Abstract] [Full Text] [Related]

  • 8. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY, Chen J, Xia CC, Huang ZX, Song B.
    J Biol Regul Homeost Agents; 2017 Aug; 31(4):1029-1036. PubMed ID: 29254310
    [Abstract] [Full Text] [Related]

  • 9. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.
    Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Claussen CD, Laniado M.
    Acta Radiol; 2000 May; 41(3):255-62. PubMed ID: 10866081
    [Abstract] [Full Text] [Related]

  • 10. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK, Byun JH, Kim HJ, Park SH, Kim N, Shin YM, Kim PN.
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [Abstract] [Full Text] [Related]

  • 11. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF, Fischer MA, Chuck N, Hunziker R, Weishaupt D, Reiner CS.
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [Abstract] [Full Text] [Related]

  • 12. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO.
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [Abstract] [Full Text] [Related]

  • 14. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL, Saito K, Araki Y, Matsubayashi J, Nagao T, Sugimoto K, Tokuuye K.
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
    Zhou ZP, Long LL, Qiu WJ, Cheng G, Huang LJ, Yang TF, Huang ZK.
    Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
    [Abstract] [Full Text] [Related]

  • 16. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
    Schelhorn J, Best J, Reinboldt MP, Gerken G, Ruhlmann M, Lauenstein TC, Antoch G, Kinner S.
    J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
    [Abstract] [Full Text] [Related]

  • 17. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
    Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf KJ, Albrecht T.
    AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
    [Abstract] [Full Text] [Related]

  • 18. "Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.
    Choi SH, Lee CH, Kim BH, Lee J, Choi JW, Park YS, Kim KA, Park CM.
    J Comput Assist Tomogr; 2013 Oct; 37(6):849-55. PubMed ID: 24270105
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage.
    Kul M, Erden A, Düşünceli Atman E.
    Br J Radiol; 2017 Apr; 90(1072):20160847. PubMed ID: 28181823
    [Abstract] [Full Text] [Related]

  • 20. Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.
    Lestra T, Kanagaratnam L, Mulé S, Janvier A, Brixi H, Cadiot G, Dohan A, Hoeffel C.
    Diagn Interv Imaging; 2018 Feb; 99(2):73-81. PubMed ID: 29339222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.